Editorials

• CLDN18.2-targeted molecular imaging and precision therapy of gastrointestinal tumors
• Comment on: “Development of a CLDN18.2-targeting immuno-PET probe for non-invasive imaging in gastrointestinal tumors”

Review Papers

• Applications and safety of gold nanoparticles as therapeutic devices in clinical trials
• Metabolomics: A useful tool for ischemic stroke research

Original Articles

• 1,8-cineole ameliorates colon injury by downregulating macrophage M1 polarization via inhibiting the HSP90-NLRP3-SGT1 complex
• Ginsenoside Rk2,a dehydroprotopanaxadiol saponin,alleviates alcoholic liver disease via regulating NLRP3 and NLRP6 inflammasome signaling pathways in mice
• Quantification of soluble epoxide hydrolase inhibitors in experimental and clinical samples using the nanobody-based ELISA
• Gut microbiota-based pharmacokinetic-pharmacodynamic study and molecular mechanism of specnuezhenide in the treatment of colorectal cancer targeting carboxylesterase
• Rapid metabolic fingerprinting with the aid of chemometric models to identify authenticity of natural medicines: Turmeric, Ocimum,and Withania somnifera study
• Eight Zhes Decoction ameliorates the lipid dysfunction of nonalcoholic fatty liver disease using integrated lipidomics,network pharmacology and pharmacokinetics
• Characterization of natural peptides in Pheretima by integrating proteogenomics and label-free peptidomics

Short Communication

• Targeted bile acids metabolomics in cholesterol gallbladder polyps and gallstones: From analytical method development towards application to clinical samples

• JOURNAL OF PHARMACEUTICAL ANALYSIS BEST PAPERS 2022